Patient Activation Program + Text Messaging for Type 2 Diabetes

This trial aims to determine if combining a patient support program with text messaging helps people with Type 2 diabetes (T2DM) adhere to their medication better than text messaging alone. It focuses on improving communication between patients and doctors, which may help control blood sugar, cholesterol, and blood pressure, and enhance patient satisfaction. Participants should have T2DM with uncontrolled blood sugar (HbA1c >8), take medication for blood pressure or cholesterol, and be able to read and text in English. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that may improve diabetes management.

The trial does not specify that you need to stop taking your current medications. In fact, all patients will continue to receive their usual care and medication for diabetes and cardiovascular disease prevention.

Research has shown that using Office-GAP (Office Guidelines Applied to Practice) with mobile text messaging is safe for individuals. This method assists people with diabetes in adhering to their medication plans. Studies have found that these programs enhance communication between patients and doctors, leading to better health outcomes. No reports of harm have emerged from using these methods.

Text messaging alone has also been studied and found to be safe. One study showed that recipients of text messages felt less stressed about their diabetes and experienced better support and understanding of their condition. They also improved their self-care.

Researchers are excited about this trial because it's exploring how digital tools can empower people with Type 2 diabetes to manage their condition more effectively. Unlike standard treatments that often rely heavily on medication alone, this trial combines mobile text messaging with practical office guidelines to support patient self-management. This approach could lead to better adherence to treatment plans and improved health outcomes by providing patients with regular reminders and personalized advice. By leveraging technology, the trial aims to make diabetes management more accessible and engaging for patients, potentially setting a new standard for chronic disease care.

Research has shown that using Office Guidelines Applied to Practice (Office-GAP) with mobile text messages can help people with Type 2 diabetes stay more engaged and communicate better with their healthcare providers. Participants in one arm of this trial will receive this combination. This method supports patients and doctors in making decisions together and helps patients take their medications more regularly. One study found that this combination led to better health outcomes than using text messages alone. Participants in another arm of this trial will receive only text messages, which have had mixed success in helping people stick to their medication schedules and manage blood sugar levels. However, when combined with Office-GAP, patients often manage their diabetes better, likely because the approach is more personalized and proactive.⁶⁷⁸⁹¹⁰